IP Library › Granted Patent US 10,633,415
Granted Patent B2
US 10,633,415 · App. 15/555,494 · Granted Apr 28, 2020

Processes for preparing pharmaceutically relevant peptides

Inventors: Scott Duncan (Bedford, MA); D. Travis Wilson (Newton, MA)
Assignee: STEALTH BIOTHERAPEUTICS CORP
C07K5/1019C07K1/02C07K1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,415
App. No.
15/555,494
Granted
Apr 28, 2020
Kind
B2
Abstract

The present technology provides methods of generating the peptides, and pharmaceutically acceptable salts of the peptides and intermediates thereof. In some embodiments, the peptide is D-Arg-2′6′-Dmt-Lys-Phe-NH 2 .

Claims (46)

1. A process for the preparation of a compound of formula VIII or a salt thereof

the method comprising reacting a compound of formula III-A or a salt thereof with a compound of formula III-B or a salt thereof to form the compound of formula VIII or the salt thereof:

wherein

A 6 together with the carbonyl group to which it is attached forms a carboxylic acid, active ester, anhydride, or acid halide;

R 1 and R 2 are each independently

(i) hydrogen;

(ii) substituted or unsubstituted C 1 -C 6 alkyl;

(iii) substituted or unsubstituted aralkyl;

(iv) substituted or unsubstituted C 3 -C 8 cycloalkyl or cycloalkylalkyl;

(v) substituted or unsubstituted C 2 -C 6 alkenyl;

(vi) an amino protecting group;

or R 1 and R 2 together form a 3, 4, 5, 6, 7, or 8 membered substituted or unsubstituted heterocyclyl or heteroaryl group;

R 8a and R 8b are each independently

where R 10 , R 11 , R 13 , and R 14 are each independently selected from H, or a C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, C 1 -C 4 alkylamino, C 1 -C 4 dialkylamino, cyano, —C(O)-alkyl, —C(O)-aryl, —C(O)-aralkyl, carboxylate, ester, amide, nitro, hydroxyl, halogen, or perhaloalkyl group, wherein each alkyl, aryl or aralkyl group is substituted or unsubstituted; and

one R 12 is —OH and the other R 12 is selected from hydrogen, —OH, halogen, C 1 -C 6 alkyl, —O—C 1 -C 6 alkyl, —NH—C 1 -C 6 alkyl, —N(C 1 -C 6 alkyl) 2 , C 1 -C 4 -perhaloalkyl, aralkyl, —O— aralkyl, —NH-aralkyl, —N(aralkyl) 2 , —N(C 1 -C 6 alkyl)(aralkyl), —C(O)-alkyl, —C(O)-aryl, or —C(O)-aralkyl, wherein each alkyl, aryl or aralkyl group is substituted or unsubstituted;

R 9 is OR′ or NR′R″; R′ at each occurrence is independently a hydrogen, or a substituted or unsubstituted alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl, heterocyclyl, or heterocyclylalkyl group; R″ is a hydrogen, or a substituted or unsubstituted alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl, heterocyclyl, or heterocyclylalkyl group;

R 22 , R 23 , and R 24 are each independently hydrogen or a C 1 -C 4 alkyl;

n is 1, 2, 3, 4, or 5;

m is 1, 2, 3, 4, or 5;

X 1 , X 2 and X 4 are independently at each occurrence hydrogen or an amino protecting group;

X 3 is R 2 , hydrogen or an amino protecting group;

Z 5 and Z 6 are each independently —NHX 1 , —C(N—X 4 )—NH—X 2 , —NX 1 C(N—X 4 )—NH—X 2 , —NX 1 (C 1- C 6 alkyl), —NX 1 (C 6 -C 10 aryl), —NX 1 (C 7 -C 12 aralkyl), or nitrogen-containing heterocyclyl or heteroaryl group wherein each alkyl, aryl, aralkyl, heterocyclyl, or heteroaryl group is substituted or unsubstituted.

2. The process of claim 1 , wherein the compound of formula III-A or the salt thereof is prepared by a method comprising converting the compound of formula III-C or a salt thereof to the compound of formula III-A or the salt thereof:

wherein W 2 is a substituted or unsubstituted alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl, heterocyclyl, or heterocyclylalkyl group.

3. The process of claim 2 , wherein W 2 is benzyl and X 3 is Boc, and converting a compound of formula IIIC comprises reductively cleaving the benzyl to H.

4. The process of claim 2 , wherein R 1 and R 22 are both H, m is 3, Z 6 is —NHC(NH)NH 2 , and R 8a is 2,6-dimethyl-4-hydroxyphenyl.

5. The process of claim 1 , wherein the compound of formula III-C or the salt thereof is prepared by a method comprising reacting a compound of formula III-D or a salt thereof with a compound of formula I-E or a salt thereof to form the compound of formula III-C or the salt thereof:

6. The process of claim 1 , wherein the compound of formula III-B or the salt thereof is prepared by a method comprising converting a compound of formula III-E or a salt thereof to the compound of formula III-B or the salt thereof:

wherein Y 2 is an amino protecting group.

7. The process of claim 6 wherein Y 2 is Cbz and converting the compound of III-E comprises reductively cleaving the Cbz to H.

8. The process of claim 6 , wherein R 9 is —NH 2 , R 23 is H, n is 4, Z 5 is —NHBoc, and R 8b is unsubstituted phenyl.

9. The process of claim 6 , wherein the compound of formula III-E or the salt thereof is prepared by a method comprising reacting a compound of formula I-B or a salt thereof with a compound of formula III-F or a salt thereof to form the compound of formula III-E or the salt thereof:

wherein A 7 together with the carbonyl group to which it is attached forms a carboxylic acid, active ester, anhydride, or acid halide.

10. The process of claim 1 , wherein the compound of formula VIII or a salt thereof is a compound of formula VIII-B or a salt thereof, wherein

R 1 is hydrogen;

X 3 is an amino protecting group susceptible to acid-mediated removal;

Z 5 and Z 6 are independently selected from —NHX 1 or —NHC(NH)—NH 2 ;

X 1 is an amino protecting group susceptible to acid-mediated removal;

m and n are independently selected from 2, 3, or 4;

R 9 is NH 2 ,

R 10 and R 14 at each occurrence are independently selected from hydrogen or C 1 -C 6 alkyl; and

one R 12 is —OH and the other R 12 is hydrogen or —OH.

11. The process of claim 10 wherein X 3 is Boc and X 1 is Boc.

12. The process of claim 10 wherein the compound of formula VIII-B or a salt thereof is reacted with an acid under anhydrous conditions to provide the deprotected tetrapeptide wherein X 3 and X 1 are both hydrogen.

13. The process of claim 12 wherein the acid is HCl.

14. The process of claim 1 wherein the salt of the compound of formula VIII or VIII-B is an aliphatic carboxylate, hydrochloride, hydrobromide, alkylsulfonate, arylsulfonate, fumarate, succinate, tartrate, oxalate, phosphate, or sulfate salt.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2021
From: STEALTH BIOTHERAPEUTICS CORP
To: STEALTH BIOTHERAPEUTICS INC.
Reel/Frame 058164/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2019
From: DUNCAN, SCOTT; WILSON, D. TRAVIS
To: STEALTH BIOTHERAPEUTICS CORP
Reel/Frame 048295/0676 →
Continuity (2)
Provisional Application 62129575 · Mar 6, 2015
Related Publication 20180044378A1 · Feb 15, 2018